Unlock instant, AI-driven research and patent intelligence for your innovation.

Biaryl and biheteroaryl compounds useful in treating iron disorders

A technology of compounds and mixtures, applied in the field of divalent metal transporter-1 inhibitors, which can solve problems such as tissue damage and increased risk

Inactive Publication Date: 2010-01-06
XENON PHARMACEUTICALS INC
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Excess accumulation of iron can lead to significant tissue damage and increased risk of concurrent diseases such as cirrhosis or hepatocellular carcinoma

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biaryl and biheteroaryl compounds useful in treating iron disorders
  • Biaryl and biheteroaryl compounds useful in treating iron disorders
  • Biaryl and biheteroaryl compounds useful in treating iron disorders

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0106] Within the various aspects of the invention described above in the Summary of the Invention, certain embodiments are preferred.

[0107] Among the compounds of general formula (I) described above in the summary of the invention, one embodiment is a compound of general formula (Ia):

[0108]

[0109] in:

[0110] R 1 is a chemical bond, -O-, -S(O) p -(where p is 0, 1 or 2), -C(R 4 ) 2 -, -C(O)- or -N(R 4 )-;

[0111] R 2a , R 2b , R 2c , R 2d and R 2e each independently selected from hydrogen, alkyl, halogen, haloalkyl, -R 6 -OR 7 ,-R 6 -CN, -R 6 -NO 2 ,-R 6 -N(R 8 ) 2 ,-R 6 -C(O)OR 8 ,-R 6 -C(O)N(R 8 ) 2 , -N(R 8 )S(O) t R 9 ,-S(O) t OR 9 ,-S(O) p R 8 ,-S(O) t N(R 8 ) 2 ,-R 6 -S-C(=NR 4 )N(R 4 )R 5 ,-R 6 -O-C(=NR 4 )N(R 4 )R 5 ,-R 6 -C(O)-N=C[N(R 4 )(R 5 )]N(R 4 )R 5 ,-R 6 -C(=NR 4 )N(R 4 )R 5 and -R 6 -N(R 7 )-C(=NR 4 )N(R 4 )R 5 , wherein each t is independently 1 or 2 and each p is 0, 1 or 2 and wherein R 2a ...

Embodiment 1

[1216] Synthesis of 2-(1-{2-[2-(1-amidinothioethyl)phenoxy]phenyl}ethyl)isothiouronium dihydrobromide

[1217]

[1218] To a stirred suspension of thiourea (0.17 g, 0.22 mmol) in water was added 48% aqueous hydrobromic acid. The mixture was stirred for 10 min, then 1-(1-hydroxyethyl)-2-(6-(1-hydroxyethyl)phenoxy)benzene (0.26 g, 0.10 mmol) was added in one portion. The mixture was stirred at 80 °C for 3 h and cooled to ambient temperature. Diethyl ether (2.0 mL) was added to the mixture. The solid was collected by filtration and dried in air to give 2-(1-{2-[2-(1-amidinothioethyl)phenoxy]phenyl}ethyl)isothiourea dihydrogen bromide acid salt (0.19g), yield 54%: 1 H NMR (300MHz, DMSO-d 6 )δ9.22(s, 4H), 9.03(s, 4H), 7.64(d, J=8.8Hz, 2H), 7.35(t, J=7.0Hz, 2H), 7.22(t, J=7.5Hz, 2H), 6.75(d, J=8.2Hz, 2H), 6.22(s, 2H), 5.44(q, J=6.8Hz, 2H), 1.76(d, J=6.8Hz, 6H); MS(ES+) m / z358.6(M+1).

Embodiment 11

[1220] Synthesis of 2-[2-(2-amidinothiomethylphenylthio)benzyl]isothiouronium dihydrobromide

[1221]

[1222] According to the procedure as described in Example 1, with non-critical changes, 1-(hydroxymethyl)-2-((6-(hydroxymethyl)phenyl)thio)benzene was used instead of 1-(1 -Hydroxyethyl)-2-(6-(1-hydroxyethyl)phenoxy)benzene to give 2-[2-(2-amidinothiomethylphenylthio) as a colorless solid Benzyl]isothiouronium dihydrobromide, the yield is 74%: 1 H NMR (300MHz, DMSO-d 6 )δ9.28(s, 4H), 9.10(s, 4H), 7.63-7.59(m, 2H), 7.41-7.32(m, 4H), 7.15-7.10(m, 2H), 4.65(s, 4H) ; MS (ES+) m / z 363.6 (M+1).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention is directed to compounds of formula (I), wherein A, B, m, n, R<1>, R<2> and R<3> are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment of iron disorders. This invention is also directed to pharmaceutical compositions comprising the compounds and methods of using the compounds to treat iron disorders.

Description

field of invention [0001] The present invention relates to diaryl and diheteroaryl compounds which are divalent metal transporter-1 inhibitors. Accordingly, the compounds of the present invention and pharmaceutical compositions comprising the compounds are useful in the treatment of iron disorders in mammals. Background of the invention [0002] Iron is an essential metal for life as it is a major component of a family of essential proteins including hemoglobin, cytochrome and NADH-CoQ reductase. Maintaining the body's iron homeostasis is critical to health because iron deficiency or excess can lead to morbidity and death. [0003] Divalent metal transporter-1 (DMT1), also known as natural resistance-associated macrophage protein-2 (NRAMP2) and divalent cation transporter-1 (DCT1), is ubiquitously expressed in vivo and involved in maintaining iron levels of transmembrane proteins. DMT1 is particularly important for the absorption of iron in the duodenum of the small intes...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C279/20C07C279/28C07C317/42C07C323/43C07D333/34A61K31/155A61K31/381A61P7/00
CPCC07C323/44C07C323/62C07C335/16C07D333/38C07C335/32C07D333/34A61P3/12A61P43/00A61P7/00A61P7/06
Inventor 麦克海里·乔威夫纳加斯瑞·柴卡琼-杰克库·卡迪厄傅健民拉金德·坎博日维什努墨西·库德穆鲁乔纳森·朗吉乐刘世峰孙建宇塞尔戈·斯维里多夫张载辉
Owner XENON PHARMACEUTICALS INC